Journal article
Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated Versus Non-Insulin Treated Diabetes Mellitus
S Biswas, D Dinh, N Andrianopoulos, J Lefkovits, A Ajani, SJ Duffy, W Chan, A Walton, A Brennan, DJ Clark, C Hiew, E Oqueli, CM Reid, D Stub, D Eccleston
American Journal of Cardiology | EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC | Published : 2021
Abstract
There are conflicting data on whether patients with insulin-treated diabetes mellitus (ITDM) have poorer outcomes compared with non-insulin treated diabetic (non-ITDM) patients following percutaneous coronary intervention (PCI). We therefore compared clinical outcomes following PCI in ITDM versus non-ITDM patients. We prospectively collected data on 4,579 patients with diabetes underwent PCI between 2005 and 2014 in a large multicenter registry and dichotomized them as having ITDM (n = 1,111) or non-ITDM (n = 3,468). The non-ITDM group was further divided into diet control only (diet-DM; n = 786) and those taking oral hypoglycemic agents (OHG-DM; n = 2,639), and clinical outcomes were compar..
View full abstractGrants
Awarded by Abbott Laboratories
Funding Acknowledgements
We would like to acknowledge the following sources of scholarship/grant support: The National Heart Foundation of Australia (Dr Biswas: reference no. 101518; Associate Professor Stub: reference no. 101908), the National Health and Medical Research Council of Australia (Professor Duffy: reference no. 1111170, Associate Professor Chan: reference no. 1052960, Professor Reid: reference no. 1045862), the Australian Government Research Training Program (Dr Biswas) and the Viertel Foundation (Associate Professor Stub). The Melbourne Interventional Group acknowledges funding from Abbott, Astra-Zeneca, Medtronic, MSD, Pfizer, Servier and The Medicines Company. These companies do not have access to data and do not have the right to review manuscripts or abstracts before publication.